Shanghai Pulmonary Hospital, Shanghai, China: Observational study in Postoperative Sore Throat, Bronchoscopy (4400 participants)
Shanghai Pulmonary Hospital, Shanghai, China: Observational study in Postoperative Sore Throat, Bronchoscopy (4400 participants). Its enrollment of 4,400 is top-decile (98th percentile of 8,879 records). Dated 10 days ago, it is in the active follow-up window. Score 55/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 4,400 · 98th percentile of 8,879 ClinicalTrialStartPulse records · 55.0x the median
Free preview: all 14 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Shanghai Pulmonary Hospital, Shanghai, China |
| Sponsor type | Academic and hospital |
| Study | Dexmedetomidine Nasal Spray and Postoperative Sore Throat After Bronchoscopy |
| NCT ID | NCT07894224 |
| Phase | Observational |
| Status | active not recruiting |
| Conditions | Postoperative Sore Throat; Bronchoscopy; Hoarseness; Dysphagia |
| Intervention types | drug, procedure |
| Target enrollment | 4400 |
| Site countries | China |
| Posted | 2026-10-26 |
| Planned start | 2026-10-01 |
| Event | Newly registered study |
| Event date | 2026-10-26 |
| enrollment percentile | 98th of 8,879 (median 80, 55.0x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Shanghai Pulmonary Hospital, Shanghai, China
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Shanghai Pulmonary Hospital, Shanghai, China + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-26
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Shanghai Pulmonary Hospital, Shanghai, China and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Shanghai Pulmonary Hospital, Shanghai, China's enrollment: 98th percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
55 / 100 Score
- Posted in the last two weeks.
- 4400 participants planned.
What is the ClinicalTrialStartPulse record for Shanghai Pulmonary Hospital, Shanghai, China?
Shanghai Pulmonary Hospital, Shanghai, China registered a Observational study (NCT07894224) in Postoperative Sore Throat targeting 4400 participants, posted 2026-10-26.
How does Shanghai Pulmonary Hospital, Shanghai, China compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 4,400 is 55.0x the median of 80 across 8,879 records. It is fresh: dated 10 days ago, inside the window where early outreach matters most.
Shanghai Pulmonary Hospital, Shanghai, China vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Shanghai Pulmonary Hospital, Shanghai, China | NONUS | 4,400 | 98th | 2026-10-26 |
| Hoffmann-La Roche | NONUS | 1,800 | 96th | 2026-10-30 |
| Janssen Pharmaceutica N.V., Belgium | NONUS | 1,314 | 95th | 2026-11-03 |
| Teva Branded Pharmaceutical Products R&D LLC | NONUS | 1,085 | 95th | 2026-11-03 |
Related records
- Calyxo, Inc.
- Hoffmann-La Roche
- Restor3D
- Kardium Inc.
- Janssen Biotech, Inc.
- Janssen Scientific Affairs, LLC
- Ethicon Endo-Surgery
- Janssen Pharmaceutica N.V., Belgium
- Janssen-Cilag International NV
- Janssen Biotech, Inc.
- Teva Branded Pharmaceutical Products R&D LLC
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
ClinicalTrialStartPulse: Observational ClinicalTrialStartPulse: Outside the US only
How to monitor Shanghai Pulmonary Hospital, Shanghai, China and peer observational records
Get new ClinicalTrialStartPulse records like Shanghai Pulmonary Hospital, Shanghai, China by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.